相似文献
1
Research on antipsychotics in India.
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S317-40. doi: 10.4103/0019-5545.69261.
2
[Antipsychotics in bipolar disorders].
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
3
Research on mood stabilizers in India.
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S355-61. doi: 10.4103/0019-5545.69265.
4
Antipsychotic Trials in Schizophrenia from India: A Systematic Review and Meta-analysis.
Indian J Pharm Sci. 2015 Nov-Dec;77(6):771-9. doi: 10.4103/0250-474x.174982.
5
Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. doi: 10.18553/jmcp.2012.18.S5-B.1.
6
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
Cochrane Database Syst Rev. 2015 Jan 16;1(1):CD009831. doi: 10.1002/14651858.CD009831.pub2.
7
Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia.
Int J Clin Pharmacol Ther. 2010 Jun;48(6):383-99. doi: 10.5414/cpp48383.
8
[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7.
9
Antipsychotic Use: Cross-Sectional Opinion Survey of Psychiatrists in India and United Kingdom.
Pharmacy (Basel). 2023 Oct 9;11(5):162. doi: 10.3390/pharmacy11050162.
10
Audit of antipsychotic prescribing in a private psychiatric hospital.
Australas Psychiatry. 2004 Sep;12(3):227-33. doi: 10.1080/j.1039-8562.2004.02099.x.
引用本文的文献
1
Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India.
Indian J Psychiatry. 2020 Nov-Dec;62(6):747-748. doi: 10.4103/psychiatry.IndianJPsychiatry_670_19. Epub 2020 Dec 12.
2
Risperidone-Induced Adverse Drug Reactions and Role of (-141 C Ins/Del) and (-759 C>T) Genetic Polymorphisms in Patients with Schizophrenia.
J Pharmacol Pharmacother. 2017 Jan-Mar;8(1):28-32. doi: 10.4103/jpp.JPP_197_16.
3
Clinical Practice Guidelines for Management of Schizophrenia.
Indian J Psychiatry. 2017 Jan;59(Suppl 1):S19-S33. doi: 10.4103/0019-5545.196972.
4
Metabolic syndrome and central obesity in depression: A cross-sectional study.
Indian J Psychiatry. 2016 Jul-Sep;58(3):281-286. doi: 10.4103/0019-5545.192021.
5
Antipsychotic Trials in Schizophrenia from India: A Systematic Review and Meta-analysis.
Indian J Pharm Sci. 2015 Nov-Dec;77(6):771-9. doi: 10.4103/0250-474x.174982.
本文引用的文献
1
A three-year naturalistic follow-up of patients receiving clozapine: Report from India.
Int J Psychiatry Clin Pract. 2002;6(3):167-71. doi: 10.1080/136515002760276108.
2
Effectiveness of clozapine: A study from North India.
Asian J Psychiatr. 2010 Mar;3(1):16-9. doi: 10.1016/j.ajp.2009.12.002. Epub 2010 Feb 4.
3
Fluphenazine decanoate in chronic schizophrenia.
Indian J Psychiatry. 1981 Jul;23(3):234-6.
4
Ect-chlorpromazine combination compared with chlorpromazine only in schizophrenia.
Indian J Psychiatry. 1981 Jul;23(3):230-3.
5
Efficacy of lithium in schizophrenia.
Indian J Psychiatry. 1981 Jul;23(3):193-9.
6
Survey of psychotropic drug prescribing pattern for long stay patients.
Indian J Psychiatry. 1990 Apr;32(2):162-5.
7
Open drug trial with haloperidol decanoate injections in schizophrenia.
Indian J Psychiatry. 1989 Apr;31(2):144-50.
8
Penfluridol maintenance therapy in schizophrenia: a controlled study.
Indian J Psychiatry. 1987 Oct;29(4):333-6.
9
Schizophrenia - electrolyte profile & the effect of treatment.
Indian J Psychiatry. 1987 Jul;29(3):275-7.
10
Serum prolactin levels in schizophrenia: effects of neuroleptic medication - a preliminary study.
Indian J Psychiatry. 1986 Jul;28(3):237-41.
Zotero 插件